Centre places purchase order for one crore doses of Zydus Cadila’s needle-free COVID vaccine
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Pfizer CEO in talks with 90 countries for COVID-19 pill
Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co Inc has priced its oral antiviral drug…
US authorises more batches of J&J COVID-19 vaccine made at Emergent
The FDA has now authorised 11 batches of the vaccine manufactured at the facility
Pfizer raises COVID vaccine sales forecast to $36 billion for 2021
The company had, in July, forecast sales of $33.5 billion from the vaccine it sells with BioNTech
Monoclonal antibody therapy prevents COVID-19: AIG Hospitals
A study by AIG Hospitals was conducted on 285 high-risk individuals and published in the International Journal of Internal…
WHO issues Emergency Use Listing for eighth COVID-19 vaccine
WHO’s EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX vaccine supply
Researchers discover new antibody that reduces severity of COVID-19 infection
The study isolated the antibody by analysing blood from a patient who had been infected with the SARS-CoV-1 virus, which caused…
India ready to produce over five billion COVID vaccine doses by end of 2022: PM Modi
Prime Minister Modi expressed satisfaction over the G20's decision to come up with a 15 per minimum corporate tax to make the…
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials
The development comes a day after the World Health Organization (WHO) sought more details from Bharat Biotech to consider its…
US to weigh authorisation of Pfizer COVID vaccine for children aged five to 11
The panel's vote is an important regulatory step in getting the vaccine into the arms of millions of children in the US where…
Review of Covaxin underway, expect a recommendation within 24 hours: WHO
The Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new…
Cipla Health develops povidone iodine-based anti-viral nasal spray effective against coronavirus
Research shows that its main component PVP-I is effective against common respiratory tract infection-causing microbes including…
India committed to supplying COVID-19 vaccines to other nations by year end
The country had suspended exports of COVID-19 vaccines in April to focus on inoculating its own population following a sudden…
Biological E hopes to roll out COVID vaccine by November-end
Biological E’s anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is currently undergoing phase-II/III…
EU regulator starts real-time review of Merck’s COVID-19 pill
Under the procedure, also known as a rolling review, the European Medicines Agency (EMA) would assess data as soon as it becomes…
COVID vaccines for kids between five and 11 likely in November: Fauci
Advisers to the US Centers for Disease Control and Prevention (CDC) will weigh in on recommendations for the vaccine at a meeting…
Modi interacts with domestic vaccine manufacturers
The vaccine manufacturers appreciated the vision and leadership of the Prime Minister in providing continuous guidance and support…
DFC to finance Biological E for expanding COVID-19 vaccine manufacturing
The agreement will help bolster near-term COVID-19 response efforts and will also benefit long-term global health in India and…
Modi addresses India on achieving milestone of 100 crore vaccinations
Acceptance that India enjoys in the world as a pharma hub will be further strengthened, Prime Minister Modi said
WHO urges G20 to step up COVID-19 vaccine donations to the south
"The @g20org countries must fulfil their dose-sharing commitments immediately," Tedros Adhanom Ghebreyesus, Director-General, WHO,…